[Directly to the 60th Pharmaceutical Machinery Exhibition] Application of Kinglai Pumps and Valves in High-end Commercial Pharmaceutical Fluid Delivery
Dental projects are expected to be included in commercial insurance, and Modern Dental and Times Angel rose by more than 8%
Biosin Biotech Appoints Mr. Joel Edwards as Chief Commercial Officer
Kangchen Pharmaceutical's KC1036 entered Phase Ib/II clinical study for the treatment of advanced digestive system tumors
On February 23, Kangchen Pharmaceutical issued an announcement saying that recently, Kangchen Pharmaceutical's "Phase Ib/II
What are the recommendations of the ACG guidelines for the diagnosis and treatment of irritable bowel syndrome (IBS)?
The price paid by medical insurance: the first step in the reform of innovative drug commercialization?
The Health and Health Commission first mentioned "off-indication use", is the commercialization of tumor drugs ready for a turnaround?
. How is the commercialization of blockbuster products?
ExxonMobil moves toward commercial start-up at LAO, Texas production facility
In order to accelerate the development and commercialization of innovative drugs, a large number of pharmaceutical companies are joining forces
arthritis has been approved by NMPA and Phase Ib/II clinical trials will be launched in the near future
The first subject of Lifetech's IBS(R) coronary stent in China's confirmatory clinical study was successfully enrolled
The electric fracturing skid with the largest single machine power in the world has been put into commercial application
Published data from Merck's pembrolizumab adjuvant treatment in patients with stage IB-IIIA non-small cell lung cancer (NSCLC)
Announcement of data from a study of pembrolizumab in adjuvant treatment of patients with stage IB-IIIA non-small cell lung cancer (NSCLC)
Pharmaceutical companies have accelerated the process of commercialization and enhanced the ability of "hematopoietic"
CAN106 injection completed the first patient with PNH in Phase Ib/I I clinical trial in China
Luye Pharma Grants Exeltis Exclusive Commercialization Rights for New Drugs in Mexico, Poland
the commercialization of long-acting COVID-19 neutralizing antibodies in China
A number of innovative drug companies have achieved outstanding commercialization performance, and sales revenue has grown strongly!